Literature DB >> 10809374

Interferons and cell growth control.

D V Kalvakolanu1.   

Abstract

Cytokines modulate cell growth, differentiation, and immune defenses in the vertebrates. Interferons (IFNs) are a unique class of cytokines that stimulate antiviral, antitumor and antigen presentation by inducing the expression of several cellular genes. Recent studies have identified a novel gene regulatory pathway activated by IFNs, which serves as a paradigm for most cytokine signal transduction pathways. A number of genes induced by IFNs participate in cell growth regulation and apoptosis. These include novel tumor suppressor genes. Although discovered as IFN-regulated factors, deletions of these genes cause leukemias in experimental models and in human patients. Genetic approaches have identified several novel regulators of apoptosis. Studies on the mechanism of action of these growth regulatory molecules are not only useful in identifying novel targets for the development of therapeutics but also help understand the molecular basis for loss of cell growth control and resistance to IFNs. This review focuses on the functions and roles of IFN regulated factors in cell growth control and mechanisms of disruption of IFN action in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10809374     DOI: 10.14670/HH-15.523

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  12 in total

Review 1.  The functions of cytokines and their uses in toxicology.

Authors:  J R Foster
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

2.  Critical roles for IFN-beta in lymphoid development, myelopoiesis, and tumor development: links to tumor necrosis factor alpha.

Authors:  Raj Deonarain; Amit Verma; Andrew C G Porter; Dirk R Gewert; Leonidas C Platanias; Eleanor N Fish
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

Review 3.  Cytokine-induced tumor suppressors: a GRIM story.

Authors:  Dhan V Kalvakolanu; Shreeram C Nallar; Sudhakar Kalakonda
Journal:  Cytokine       Date:  2010-04-10       Impact factor: 3.861

4.  Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells.

Authors:  B H Morrison; J A Bauer; D V Kalvakolanu; D J Lindner
Journal:  J Biol Chem       Date:  2001-05-03       Impact factor: 5.157

5.  GRIM-19 Expression and Function in Human Gliomas.

Authors:  Yong-Hao Jin; Shin Jung; Shu-Guang Jin; Tae-Young Jung; Kyung-Sub Moon; In-Young Kim
Journal:  J Korean Neurosurg Soc       Date:  2010-07-31

6.  Filamin B serves as a molecular scaffold for type I interferon-induced c-Jun NH2-terminal kinase signaling pathway.

Authors:  Young Joo Jeon; Joon Seok Choi; Jung Yun Lee; Kyung Ryun Yu; Seung Hyeun Ka; Yongcheol Cho; Eui-Ju Choi; Sung Hee Baek; Jae Hong Seol; Dongeun Park; Ok Sun Bang; Chin Ha Chung
Journal:  Mol Biol Cell       Date:  2008-09-24       Impact factor: 4.138

7.  The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3.

Authors:  Jun Zhang; Jinbo Yang; Sanjit K Roy; Silvia Tininini; Jiadi Hu; Jacqueline F Bromberg; Valeria Poli; George R Stark; Dhananjaya V Kalvakolanu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-16       Impact factor: 11.205

8.  Inflammation activates the interferon signaling pathways in taste bud cells.

Authors:  Hong Wang; Minliang Zhou; Joseph Brand; Liquan Huang
Journal:  J Neurosci       Date:  2007-10-03       Impact factor: 6.167

9.  GRIM-19: A Double-edged Sword that Regulates Anti-Tumor and Innate Immune Responses.

Authors:  Shreeram C Nallar; Sudhakar Kalakonda; Peng Sun; Dhan V Kalvakolanu
Journal:  Transl Oncogenomics       Date:  2008-03-17

10.  Pivotal Role for Cxcr2 in Regulating Tumor-Associated Neutrophil in Breast Cancer.

Authors:  Colin Timaxian; Christoph F A Vogel; Charlotte Orcel; Diana Vetter; Camille Durochat; Clarisse Chinal; Phuong NGuyen; Marie-Laure Aknin; Françoise Mercier-Nomé; Martin Davy; Isabelle Raymond-Letron; Thi-Nhu-Ngoc Van; Sarah D Diermeier; Anastasia Godefroy; Magali Gary-Bobo; Franck Molina; Karl Balabanian; Gwendal Lazennec
Journal:  Cancers (Basel)       Date:  2021-05-25       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.